Inflation: Why Houston employers should prioritize employee financial well-being

guest column

When employers recognize the interconnectedness of employee wellbeing and business success, they lay the foundation for a sustainable future for their organization. Photo via Getty Images

Inflation impacts everyone, including individuals, the workforce and business leaders. As the cost of living continues to rise, employees face diminishing purchasing power, shrinking retirement savings and higher stress levels.

In PwC’s 2023 Employee Financial Wellness Survey, 57 percent of respondents named finances as the top cause of stress in their lives. With these factors in play, employers should consider the support they provide for employees’ financial health, which directly impacts them emotionally and physically. When any one of these elements are out of alignment, employee productivity and engagement suffer, in turn impacting business success.

The Inflation Conundrum

Inflation is the silent financial predator that affects every aspect of life. Coupled with the financial responsibilities of the workforce, like child or elder care and college tuition, inflation erodes the value of money over time. As prices surge and the purchasing power of the dollar declines, the effects can ripple through a person’s life, including the workplace. Here are several ways inflation can impact employees:

  • Diminished Salary Satisfaction: Inflation does not discriminate. When prices rise, compensation does not follow suit at a one-to-one ratio. This can lead employees to feel their salaries are no longer sufficient to maintain their desired standard of living. Employees who do not have enough for their daily needs are not saving for their future goals, which exacerbates salary dissatisfaction.
  • Eroding Retirement Savings: A 401(k) is a critical component for many employees’ long-term financial strategy. However, inflation can interfere as the cost of living finds employees allocating less to their retirement accounts. Fewer contributions can have a significant long-term impact on the workforce’s financial goals.
  • Increased Stress and Anxiety: Financial insecurity and the higher cost of living can impact mental health. The stress and anxiety common with financial challenges often makes its way into the workplace, resulting in decreased productivity and engagement, interpersonal tension and employees seeking additional or alternative employment opportunities.

The PwC survey underlines how financial stress impacts employees beyond their pocketbooks with 50% or more reporting a negative impact on sleep, mental health and self-esteem. While physical health and relationships at home are not far behind at 44 percent and 40 percent, respectively.

The Holistic Approach to Employee Well-being

In times of economic uncertainty, it becomes vital for employers to prioritize their employees' well-being. A holistic approach, proactively addressing emotional, physical and financial health, can mitigate the negative impacts of inflation and foster a more engaged workforce. A few strategies to consider include:

  • Employee Assistance Programs (EAPs): Employee Assistance Programs are a valuable resource for employees facing personal or financial challenges. These programs provide access to counseling services, financial advice and other forms of support. Offering EAPs demonstrates an employer’s commitment to the overall well-being of their workforce.
  • Greater 401(k) Contributions: Employers can consider increasing the company’s 401(k) contributions in recognition of the strain inflation places on employees' retirement savings. A higher match encourages employees to save more and helps offset the erosion of their retirement savings due to inflation. It is important to note, this is not a short-term solution. Once implemented, it is difficult to walk back these changes without negatively impacting employee morale.
  • Open Communication: Open and transparent communication with employees is always key but is especially paramount to understanding their concerns and needs during periods of inflation. Regular surveys or meetings to gauge employees' financial stress levels and field suggestions for improvement can provide valuable insights.
  • Financial Incentives: Though it is not an immediate fix to immediate financial needs, incentivizing employees to save and invest can be a win-win strategy. Employers can offer financial literacy programs, workshops, or provide bonuses or incentives tied to employees' financial goals. These resources, trainings and initiatives can empower employees to make better informed financial decisions.

The Consequences

Business leaders should realize inflation impacts more than balance sheets, sending shockwaves deep into the health, morale and productivity of their workforce. And when employees are suffering with their mental, physical or financial health, they are more prone to look for employment where these needs are met.

Employers are at a crossroads where they can create a workplace culture that not only supports employees during times of inflation but also fosters resilience and loyalty. EAPs, increased 401(k) contributions, open communication, and financial incentives are just a few of the strategies that employers can implement to ease the burden of inflation on their workforce.

When employers recognize the interconnectedness of employee wellbeing and business success, they lay the foundation for a sustainable future for their organization. Employees can weather the storm and eventually thrive when armed with the proper support and tools.


------

Kelly Yeates is vice president of service operations with Insperity, a leading provider of human resources and business performance solutions.

From Your Site Articles
Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Greentown Labs names Lawson Gow as its new Houston leader

head of hou

Greentown Labs has named Lawson Gow as its Head of Houston.

Gow is the founder of The Cannon, a coworking space with seven locations in the Houston area, with additional partner spaces. He also recently served as managing partner at Houston-based investment and advisory firm Helium Capital. Gow is the son of David Gow, founder of Energy Capital's parent company, Gow Media.

According to Greentown, Gow will "enhance the founder experience, cultivate strategic partnerships, and accelerate climatetech solutions" in his new role.

“I couldn’t be more excited to join Greentown at this critical moment for the energy transition,” Gow said in a news release. “Greentown has a fantastic track record of supporting entrepreneurs in Houston, Boston, and beyond, and I am eager to keep advancing our mission in the energy transition capital of the world.”

Gow has also held analyst, strategy and advising roles since graduating from Rice University.

“We are thrilled to welcome Lawson to our leadership team,” Georgina Campbell Flatter, CEO of Greentown Labs, added in the release. “Lawson has spent his career building community and championing entrepreneurs, and we look forward to him deepening Greentown’s support of climate and energy startups as our Head of Houston.”

Gow is the latest addition to a series of new hires at Greentown Labs following a leadership shakeup.

Flatter was named as the organization's new CEO in February, replacing Kevin Dutt, Greentown’s interim CEO, who replaced Kevin Knobloch after he announced that he would step down in July 2024 after less than a year in the role.

Greentown also named Naheed Malik its new CFO in January.

Timmeko Moore Love was named the first Houston general manager and senior vice president of Greentown Labs. According to LinkedIn, she left the role in January.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston foundation grants $27M to support Texas chemistry research

fresh funding

Houston-based The Welch Foundation has doled out $27 million in its latest round of grants for chemical research, equipment and postdoctoral fellowships.

According to a June announcement, $25.5 million was allocated for the foundation's longstanding research grants, which provide $100,000 per year in funding for three years to full-time, regular tenure or tenure-track faculty members in Texas. The foundation made 85 grants to faculty at 16 Texas institutions for 2025, including:

  • Michael I. Jacobs, assistant professor in the chemistry and biochemistry department at Texas State University, who is investigating the structure and thermodynamics of intrinsically disordered proteins, which could "reveal clues about how life began," according to the foundation.
  • Kendra K. Frederick, assistant professor in the biophysics department at The University of Texas Southwestern Medical Center, who is studying a protein linked to Parkinson’s disease.
  • Jennifer S. Brodbelt, professor in chemistry at The University of Texas at Austin, who is testing a theory called full replica symmetry breaking (fullRSB) on glass-like materials, which has implications for complex systems in physics, chemistry and biology.

Additional funding will be allocated to the Welch Postdoctoral Fellows of the Life Sciences Research Foundation. The program provides three-year fellowships to recent PhD graduates to support clinical research careers in Texas. Two fellows from Rice University and Baylor University will receive $100,000 annually for three years.

The Welch Foundation also issued $975,000 through its equipment grant program to 13 institutions to help them develop "richer laboratory experience(s)." The universities matched funds of $352,346.

Since 1954, the Welch Foundation has contributed over $1.1 billion for Texas-nurtured advancements in chemistry through research grants, endowed chairs and other chemistry-related ventures. Last year, the foundation granted more than $40.5 million in academic research grants, equipment grants and fellowships.

“Through funding basic chemical research, we are actively investing in the future of humankind,” Adam Kuspa, president of The Welch Foundation, said the news release. “We are proud to support so many talented researchers across Texas and continue to be inspired by the important work they complete every day.”

New Houston biotech co. developing capsules for hard-to-treat tumors

biotech breakthroughs

Houston company Sentinel BioTherapeutics has made promising headway in cancer immunotherapy for patients who don’t respond positively to more traditional treatments. New biotech venture creation studio RBL LLC (pronounced “rebel”) recently debuted the company at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Rima Chakrabarti is a neurologist by training. Though she says she’s “passionate about treating the brain,” her greatest fervor currently lies in leading Sentinel as its CEO. Sentinel is RBL’s first clinical venture, and Chakrabarti also serves as cofounder and managing partner of the venture studio.

The team sees an opportunity to use cytokine interleukin-2 (IL-2) capsules to fight many solid tumors for which immunotherapy hasn't been effective in the past. “We plan to develop a pipeline of drugs that way,” Chakrabarti says.

This may all sound brand-new, but Sentinel’s research goes back years to the work of Omid Veiseh, director of the Rice Biotechnology Launch Pad (RBLP). Through another, now-defunct company called Avenge Bio, Veiseh and Paul Wotton — also with RBLP and now RBL’s CEO and chairman of Sentinel — invested close to $45 million in capital toward their promising discovery.

From preclinical data on studies in mice, Avenge was able to manufacture its platform focused on ovarian cancer treatments and test it on 14 human patients. “That's essentially opened the door to understanding the clinical efficacy of this drug as well as it's brought this to the attention of the FDA, such that now we're able to continue that conversation,” says Chakrabarti. She emphasizes the point that Avenge’s demise was not due to the science, but to the company's unsuccessful outsourcing to a Massachusetts management team.

“They hadn't analyzed a lot of the data that we got access to upon the acquisition,” explains Chakrabarti. “When we analyzed the data, we saw this dose-dependent immune activation, very specific upregulation of checkpoints on T cells. We came to understand how effective this agent could be as an immune priming agent in a way that Avenge Bio hadn't been developing this drug.”

Chakrabarti says that Sentinel’s phase II trials are coming soon. They’ll continue their previous work with ovarian cancer, but Chakrabarti says that she also believes that the IL-2 capsules will be effective in the treatment of endometrial cancer. There’s also potential for people with other cancers located in the peritoneal cavity, such as colorectal cancer, gastrointestinal cancer and even primary peritoneal carcinomatosis.

“We're delivering these capsules into the peritoneal cavity and seeing both the safety as well as the immune activation,” Chakrabarti says. “We're seeing that up-regulation of the checkpoint that I mentioned. We're seeing a strong safety signal. This drug was very well-tolerated by patients where IL-2 has always had a challenge in being a well-tolerated drug.”

When phase II will take place is up to the success of Sentinel’s fundraising push. What we do know is that it will be led by Amir Jazaeri at MD Anderson Cancer Center. Part of the goal this summer is also to create an automated cell manufacturing process and prove that Sentinel can store its product long-term.

“This isn’t just another cell therapy,” Chakrabarti says.

"Sentinel's cytokine factory platform is the breakthrough technology that we believe has the potential to define the next era of cancer treatment," adds Wotton.

View All Listings